title: Efficacy and indications of CSII revisited: the Hotel-Dieu cohort.
authors.forename: M J
authors.initials: MJ
authors.lastname: Haardt
authors.forename: C
authors.initials: C
authors.lastname: Berne
authors.forename: C
authors.initials: C
authors.lastname: Dorange
authors.forename: G
authors.initials: G
authors.lastname: Slama
authors.forename: J L
authors.initials: JL
authors.lastname: Selam
mesh_terms: D000328:Adult; D015331:Cohort Studies; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000453:epidemiology; D004630:Emergencies / Q000453:epidemiology; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007003:Hypoglycemia / Q000453:epidemiology; D007332:Insulin Infusion Systems / Q000009:adverse effects; D008297:Male; D012189:Retrospective Studies
chemical_list: D006442:Glycated Hemoglobin